Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Avicanna Inc
(OP:
AVCNF
)
0.3916
+0.0016 (+0.41%)
Streaming Delayed Price
Updated: 11:00 AM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
10,006
Open
0.3768
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.3900
Today's Range
0.3768 - 0.3916
52wk Range
0.1862 - 0.5320
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
This Company Is Bringing Medical Marijuana Telehealth To Over Half The U.S.
March 01, 2024
MMJ.com, a telehealth platform providing access to medical marijuana, has expanded its services to 26 states. This expansion allows patients to consult state-certified doctors online for medical...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Can Cannabis Treat Severe Forms Of Epilepsy? New Medicine Sparks Hope As Colombia's Weed Industry Goes Global
February 14, 2024
Clever Leaves Holdings Inc.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Performance
YTD
+58.22%
+58.22%
1 Month
+18.31%
+18.31%
3 Month
+39.66%
+39.66%
6 Month
+17.11%
+17.11%
1 Year
+27.64%
+27.64%
More News
Read More
CBD-Focused Avicanna Taps Into European Market Via Exclusive Pharma Supply Deal
February 05, 2024
Via
Benzinga
CBD-Focused Avicanna Announces Funding Boost For Research And Development
December 05, 2023
Via
Benzinga
Avicanna Inc.: Medical Marijuana Sales Reach Record 713% YoY Growth In Q3, Introduces New Platform
November 14, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From August 25, 2023
August 25, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Marijuana Stock Movers For August 23, 2023
August 23, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Canadian Cannabis Producer Reports Revenue Spike And Improved Margins In Q2, But What About Net Loss?
August 15, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers
August 07, 2023
Via
Benzinga
Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers
August 17, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
This Cannabis Company Just Launched Medical Marijuana Care Platform And Finalized Important Acquisition
August 01, 2023
Via
Benzinga
Avicanna Reveals The Initial Network Of Brands On Its Cannabis Care Platform
July 28, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From August 16, 2023
August 16, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From July 25, 2023
July 25, 2023
Via
Benzinga
Cannabis Stock Movers For August 10, 2023
August 10, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
European Cannabis Q2 2023 Quarterly Update
July 25, 2023
Via
Talk Markets
Avicanna's SMGH Exports Aureus Branded CBD And CBG Into Paraguay
July 17, 2023
Via
Benzinga
Marijuana Stock Movers For August 8, 2023
August 08, 2023
Via
Benzinga
Two Pot Companies Continue To Focus On Cannabinoid-Based Self-Emulsifying Drug Delivery Systems
June 26, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From August 4, 2023
August 04, 2023
Via
Benzinga
Avicanna Sponsors New Medical Cannabis Education And Training Campaign In Canada
June 22, 2023
Via
Benzinga
Avicanna And Langara College Team Up For Cannabinoid-Based Translational Research
June 13, 2023
Via
Benzinga
Marijuana Stock Movers For July 31, 2023
July 31, 2023
Via
Benzinga
Shoppers Drug Mart Signs Definitive Cannabis Asset Sale Agreement With Avicanna
May 29, 2023
Via
Benzinga
These 3 Experts Will Help Regulate Rhode Island's Marijuana Market & Other Cannabis Appointments
May 19, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.